- What actions to take as a GP to be seen by an insurer as a long-term strategic partner rather than just another distribution channel?
- How can UL teams and GPs ensure that the product story sold to policyholders matches how the fund really behaves?
- When markets or liquidity come under pressure, what concrete behaviours should UL teams expect from GP to protect policyholders and the platform?
- How will the UL teams - GP distribution relationship need to evolve as volumes and retail exposure grow?
